Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

In vivo validation of a Pb203-SPECT imaging probe for image-guided alpha particle therapy for metastatic melanoma.

Izabela Tworowska, Nilesh Wagh, Mengh Li, Sanjay Thamake, Ebrahim Delpassand and Michael Schultz
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 421;
Izabela Tworowska
2RadioMedix Inc., RITA Foundation Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nilesh Wagh
2RadioMedix Inc., RITA Foundation Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengh Li
3The University of Iowa Iowa city IA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay Thamake
2RadioMedix Inc., RITA Foundation Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ebrahim Delpassand
1Excel Diagnostics & Nuclear Oncology Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schultz
4University of Iowa Iowa city IA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 421

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Izabela Tworowska2,
  2. Nilesh Wagh2,
  3. Mengh Li3,
  4. Sanjay Thamake2,
  5. Ebrahim Delpassand1 and
  6. Michael Schultz4
  1. 1Excel Diagnostics & Nuclear Oncology Center Houston TX United States
  2. 2RadioMedix Inc., RITA Foundation Houston TX United States
  3. 3The University of Iowa Iowa city IA United States
  4. 4University of Iowa Iowa city IA United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016500
Jun 20164900
Jul 20161300
Aug 20161000
Sep 2016900
Oct 2016600
Nov 20161500
Dec 20161200
Jan 20171700
Feb 20172200
Mar 2017800
Apr 2017700
May 2017500
Jun 20171300
Jul 2017500
Aug 2017500
Sep 2017400
Oct 20171100
Nov 20171300
Dec 2017300
Jan 2018300
Feb 2018600
Mar 2018200
Apr 2018300
May 2018500
Jul 2018100
Aug 2018300
Sep 2018400
Oct 2018200
Nov 2018400
Jan 2019300
Feb 2019300
Mar 2019800
Apr 2019100
May 2019500
Jun 2019500
Jul 2019200
Aug 2019200
Sep 2019800
Oct 2019100
Nov 2019300
Dec 2019300
Jan 2020400
Feb 2020600
Mar 20202600
Apr 20201200
May 2020300
Jun 2020300
Jul 2020700
Aug 20201700
Sep 20203300
Oct 20201000
Nov 20202300
Dec 2020900
Jan 2021300
Feb 20211100
Mar 20211300
Apr 20212700
May 2021700
Jun 2021600
Jul 20211800
Aug 20213500
Sep 20211600
Oct 20213200
Nov 20217400
Dec 20214100
Jan 20227900
Feb 20222700
Mar 20222900
Apr 20222600
May 20222900
Jun 2022800
Jul 2022700
Aug 2022500
Sep 2022200
Oct 2022600
Nov 2022400
Dec 2022400
Jan 20231000
Feb 2023700
Mar 2023400
Apr 2023600
May 2023300
Jun 2023600
Jul 2023400
Aug 2023400
Sep 2023600
Oct 2023400
Nov 2023600
Dec 2023600
Jan 2024600
Feb 20241100
Mar 20241300
Apr 2024800
May 2024400
Jun 2024300
Jul 2024300
Aug 20241500
Sep 20241000
Oct 2024800
Nov 20241300
Dec 2024700
Jan 20251700
Feb 2025800
Mar 2025500
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In vivo validation of a Pb203-SPECT imaging probe for image-guided alpha particle therapy for metastatic melanoma.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In vivo validation of a Pb203-SPECT imaging probe for image-guided alpha particle therapy for metastatic melanoma.
Izabela Tworowska, Nilesh Wagh, Mengh Li, Sanjay Thamake, Ebrahim Delpassand, Michael Schultz
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 421;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In vivo validation of a Pb203-SPECT imaging probe for image-guided alpha particle therapy for metastatic melanoma.
Izabela Tworowska, Nilesh Wagh, Mengh Li, Sanjay Thamake, Ebrahim Delpassand, Michael Schultz
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 421;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

Imaging Tumor Response to Therapy

  • Use of paired FDG and 18F-Fluoride PET to predict response to therapy in patients with bone dominant metastases from breast cancer
  • In vitro and in vivo imaging of irradiation induced changes in PARP1 expression in oral cancer cell lines
  • Non-invasive monitoring of lymphocyte response to glucocorticoid-induced TNF receptor-related protein agonism with an anti-CD3ε PET probe
Show more Imaging Tumor Response to Therapy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire